Value of coronary computed tomography angiography in tailoring aspirin therapy for primary prevention of atherosclerotic events in patients at high risk with diabetes mellitus

American Journal of Cardiology

Volumn 117, Issue 6, 2016, Pages 887-893

  Dimitriu Leen, Aukelien C ^a   Scholte, Arthur J H A ^a   Van Rosendael, Alexander R ^a,b   Van Den Hoogen, Inge J ^a   Kharagjitsingh, Aantje V ^a,c   Wolterbeek, Ron ^a   Knuuti, Juhani ^d   Kroft, Lucia J M ^a   Delgado, Victoria ^a   Jukema, J Wouter ^a   De Graaf, Michiel A ^a   Bax, Jeroen J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b INTERUNIVERSITY CARDIOLOGY INSTITUTE OF THE NETHERLANDS   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ANGIOCARDIOGRAPHY; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CORONARY ARTERY CALCIUM SCORE; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIMARY PREVENTION; PRIORITY JOURNAL; THORAX PAIN; AGED; BODY MASS; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ANGIOGRAPHY; EVALUATION STUDY; INSULIN DEPENDENT DIABETES MELLITUS; MIDDLE AGED; NETHERLANDS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; PREVALENCE; PROCEDURES; PROSPECTIVE STUDY; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BODY MASS INDEX; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NETHERLANDS; PREDICTIVE VALUE OF TESTS; PREVALENCE; PRIMARY PREVENTION; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84959473170     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.12.023     Document Type: Article

References (30)

1. L. Ryden, P.J. Grant, S.D. Anker, C. Berne, F. Cosentino, N. Danchin, C. Deaton, J. Escaned, H.P. Hammes, H. Huikuri, M. Marre, N. Marx, L. Mellbin, J. Ostergren, C. Patrono, P. Seferovic, M.S. Uva, M.R. Taskinen, M. Tendera, J. Tuomilehto, P. Valensi, J.L. Zamorano, J.L. Zamorano, S. Achenbach, H. Baumgartner, J.J. Bax, H. Bueno, V. Dean, C. Deaton, C. Erol, R. Fagard, R. Ferrari, D. Hasdai, A.W. Hoes, P. Kirchhof, J. Knuuti, P. Kolh, P. Lancellotti, A. Linhart, P. Nihoyannopoulos, M.F. Piepoli, P. Ponikowski, P.A. Sirnes, J.L. Tamargo, M. Tendera, A. Torbicki, W. Wijns, S. Windecker, G. De Backer, P.A. Sirnes, E.A. Ezquerra, A. Avogaro, L. Badimon, E. Baranova, H. Baumgartner, J. Betteridge, A. Ceriello, R. Fagard, C. Funck-Brentano, D.C. Gulba, D. Hasdai, A.W. Hoes, J.K. Kjekshus, J. Knuuti, P. Kolh, E. Lev, C. Mueller, L. Neyses, P.M. Nilsson, J. Perk, P. Ponikowski, Z. Reiner, N. Sattar, V. Schachinger, A. Scheen, H. Schirmer, A. Stromberg, S. Sudzhaeva, J.L. Tamargo, M. Viigimaa, C. Vlachopoulos, and R.G. Xuereb ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD) Eur Heart J 34 2013 3035 3087
2. J. Perk, G. De Backer, H. Gohlke, I. Graham, Z. Reiner, M. Verschuren, C. Albus, P. Benlian, G. Boysen, R. Cifkova, C. Deaton, S. Ebrahim, M. Fisher, G. Germano, R. Hobbs, A. Hoes, S. Karadeniz, A. Mezzani, E. Prescott, L. Ryden, M. Scherer, M. Syvanne, W.J. Scholte op Reimer, C. Vrints, D. Wood, J.L. Zamorano, and F. Zannad European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) Eur Heart J 33 2012 1635 1701
3. R.B. D'Agostino Sr., R.S. Vasan, M.J. Pencina, P.A. Wolf, M. Cobain, J.M. Massaro, and W.B. Kannel General cardiovascular risk profile for use in primary care: the Framingham Heart Study Circulation 117 2008 743 753
4. R.M. Conroy, K. Pyorala, A.P. Fitzgerald, S. Sans, A. Menotti, G. De Backer, D. De Bacquer, P. Ducimetiere, P. Jousilahti, U. Keil, I. Njolstad, R.G. Oganov, T. Thomsen, H. Tunstall-Pedoe, A. Tverdal, H. Wedel, P. Whincup, L. Wilhelmsen, and I.M. Graham Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 2003 987 1003
5. R.J. Stevens, V. Kothari, A.I. Adler, and I.M. Stratton The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56) Clin Sci (Lond) 101 2001 671 679
6. J. Cederholm, K. Eeg-Olofsson, B. Eliasson, B. Zethelius, P.M. Nilsson, and S. Gudbjornsdottir Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register Diabetes Care 31 2008 2038 2043
7. Y. Arad, K.J. Goodman, M. Roth, D. Newstein, and A.D. Guerci Coronary calcification, coronary disease risk factors, C-reactive protein, and atherosclerotic cardiovascular disease events: the St. Francis Heart Study J Am Coll Cardiol 46 2005 158 165
8. D.V. Anand, E. Lim, A. Lahiri, and J.J. Bax The role of non-invasive imaging in the risk stratification of asymptomatic diabetic subjects Eur Heart J 27 2006 905 912
9. Collaborative overview of randomised trials of antiplatelet therapy-I: prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration BMJ 308 1994 81 106
10. M. Xie, Z. Shan, Y. Zhang, S. Chen, W. Yang, W. Bao, Y. Rong, X. Yu, F.B. Hu, and L. Liu Aspirin for primary prevention of cardiovascular events: meta-analysis of randomized controlled trials and subgroup analysis by sex and diabetes status PLoS One 9 2014 e90286
11. J. Belch, A. MacCuish, I. Campbell, S. Cobbe, R. Taylor, R. Prescott, R. Lee, J. Bancroft, S. MacEwan, J. Shepherd, P. Macfarlane, A. Morris, R. Jung, C. Kelly, A. Connacher, N. Peden, A. Jamieson, D. Matthews, G. Leese, J. McKnight, I. O'Brien, C. Semple, J. Petrie, D. Gordon, S. Pringle, R. MacWalter Prevention of Progression of Arterial Disease, Diabetes Study Group, Diabetes Registry Group, Royal College of Physicians Edinburgh The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease BMJ 337 2008 a1840
12. M. Pignone, M.J. Alberts, J.A. Colwell, M. Cushman, S.E. Inzucchi, D. Mukherjee, R.S. Rosenson, C.D. Williams, P.W. Wilson, and M.S. Kirkman Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation Diabetes Care 33 2010 1395 1402
13. J.S. Rana, A. Dunning, S. Achenbach, M. Al-Mallah, M.J. Budoff, F. Cademartiri, T.Q. Callister, H.J. Chang, V.Y. Cheng, K. Chinnaiyan, B.J. Chow, R. Cury, A. Delago, G. Feuchtner, M. Hadamitzky, J. Hausleiter, P. Kaufmann, R.P. Karlsberg, Y.J. Kim, J. Leipsic, T.M. Labounty, F.Y. Lin, E. Maffei, G. Raff, T.C. Villines, L.J. Shaw, D.S. Berman, and J.K. Min Differences in prevalence, extent, severity, and prognosis of coronary artery disease among patients with and without diabetes undergoing coronary computed tomography angiography: results from 10,110 individuals from the CONFIRM (COronary CT Angiography EvaluatioN for Clinical Outcomes): an InteRnational Multicenter Registry Diabetes Care 35 2012 1787 1794
14. J.M. van Werkhoven, J.D. Schuijf, O. Gaemperli, J.W. Jukema, L.J. Kroft, E. Boersma, A. Pazhenkottil, I. Valenta, G. Pundziute, A. de Roos, E.E. van der Wall, P.A. Kaufmann, and J.J. Bax Incremental prognostic value of multi-slice computed tomography coronary angiography over coronary artery calcium scoring in patients with suspected coronary artery disease Eur Heart J 30 2009 2622 2629
15. A.W. Leber, A. Knez, A. Becker, C. Becker, F. von Ziegler, K. Nikolaou, C. Rist, M. Reiser, C. White, G. Steinbeck, and P. Boekstegers Accuracy of multidetector spiral computed tomography in identifying and differentiating the composition of coronary atherosclerotic plaques: a comparative study with intracoronary ultrasound J Am Coll Cardiol 43 2004 1241 1247
16. G. Davi, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
17. A. Natarajan, A.G. Zaman, and S.M. Marshall Platelet hyperactivity in type 2 diabetes: role of antiplatelet agents Diab Vasc Dis Res 5 2008 138 144
18. MAAS Investigators Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS) Lancet 344 1994 633 638
19. H. Ogawa, M. Nakayama, T. Morimoto, S. Uemura, M. Kanauchi, N. Doi, H. Jinnouchi, S. Sugiyama, and Y. Saito Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial JAMA 300 2008 2134 2141
20. G. De Berardis, G. Lucisano, A. D'Ettorre, F. Pellegrini, V. Lepore, G. Tognoni, and A. Nicolucci Association of aspirin use with major bleeding in patients with and without diabetes JAMA 307 2012 2286 2294
21. M. Pignone, M.J. Alberts, J.A. Colwell, M. Cushman, S.E. Inzucchi, D. Mukherjee, R.S. Rosenson, C.D. Williams, P.W. Wilson, and M.S. Kirkman Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation Circulation 121 2010 2694 2701
22. J.L. Rosenzweig, E. Ferrannini, S.M. Grundy, S.M. Haffner, R.J. Heine, E.S. Horton, and R. Kawamori Primary prevention of cardiovascular disease and type 2 diabetes in patients at metabolic risk: an endocrine society clinical practice guideline J Clin Endocrinol Metab 93 2008 3671 3689
23. T.K. Schramm, G.H. Gislason, L. Kober, S. Rasmussen, J.N. Rasmussen, S.Z. Abildstrom, M.L. Hansen, F. Folke, P. Buch, M. Madsen, A. Vaag, and C. Torp-Pedersen Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people Circulation 117 2008 1945 1954
24. U. Bulugahapitiya, S. Siyambalapitiya, J. Sithole, and I. Idris Is diabetes a coronary risk equivalent? Systematic review and meta-analysis Diabet Med 26 2009 142 148
25. G.M. Park, S.W. Lee, Y.R. Cho, C.J. Kim, J.S. Cho, M.W. Park, S.H. Her, J.M. Ahn, J.Y. Lee, D.W. Park, S.J. Kang, Y.H. Kim, C.W. Lee, E.H. Koh, W.J. Lee, M.S. Kim, K.U. Lee, J.W. Kang, T.H. Lim, S.W. Park, S.J. Park, and J.Y. Park Coronary computed tomographic angiographic findings in asymptomatic patients with type 2 diabetes mellitus Am J Cardiol 113 2014 765 771
26. B.J. Chow, G. Small, Y. Yam, L. Chen, R. McPherson, S. Achenbach, M. Al-Mallah, D.S. Berman, M.J. Budoff, F. Cademartiri, T.Q. Callister, H.J. Chang, V.Y. Cheng, K. Chinnaiyan, R. Cury, A. Delago, A. Dunning, G. Feuchtner, M. Hadamitzky, J. Hausleiter, R.P. Karlsberg, P.A. Kaufmann, Y.J. Kim, J. Leipsic, T. LaBounty, F. Lin, E. Maffei, G.L. Raff, L.J. Shaw, T.C. Villines, and J.K. Min Prognostic and therapeutic implications of statin and aspirin therapy in individuals with nonobstructive coronary artery disease: results from the CONFIRM (COronary CT Angiography EvaluatioN for Clinical Outcomes: an InteRnational Multicenter registry) registry Arterioscler Thromb Vasc Biol 35 2015 981 989
27. M.G. Silverman, M.J. Blaha, M.J. Budoff, J.J. Rivera, P. Raggi, L.J. Shaw, D. Berman, T. Callister, J.A. Rumberger, J.S. Rana, R.S. Blumenthal, and K. Nasir Potential implications of coronary artery calcium testing for guiding aspirin use among asymptomatic individuals with diabetes Diabetes Care 35 2012 624 626
28. J. Leem, E. Hee Koh, E. Jeong, J.E. Jang, S.W. Lee, J.W. Kang, T.H. Lim, W.J. Lee, M.S. Kim, J.Y. Park, and K.U. Lee Prevalence of angiographically defined obstructive coronary artery disease in asymptomatic patients with type 2 diabetes according to the coronary calcium score Intern Med 51 2012 3017 3023
29. J.A. Ambrose, M.A. Tannenbaum, D. Alexopoulos, C.E. Hjemdahl-Monsen, J. Leavy, M. Weiss, S. Borrico, R. Gorlin, and V. Fuster Angiographic progression of coronary artery disease and the development of myocardial infarction J Am Coll Cardiol 12 1988 56 62
30. G. Koulaouzidis, D. Charisopoulou, S. Maffrett, M. Tighe, P.J. Jenkins, and T. McArthur Progression of coronary artery calcification in asymptomatic individuals with pre-existing calcium score Int Angiol 32 2013 327 331